Root Financial Partners
RCKT icon

Root Financial Partners’s Rocket Pharmaceuticals RCKT Stock Holding History

Root Financial Partners’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.28K Buy
+486
New +$1.68K ﹤0.01% 2850
2026
Q2 		– Sell
-840
Closed -$3.01K – 2522
2026
Q1 		$3.01K Buy
+840
New +$3.34K ﹤0.01% 2157

Other funds holding RCKT

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Root Financial Partners's RCKT Position: Q3 2026 in Review

Root Financial Partners opened a new position in Rocket Pharmaceuticals (RCKT) in Q3 2026: 486 shares worth $1.28K. The stake represents ﹤0.01% of the portfolio and ranks #2850 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in RCKT as recently as Q1 2026.

Root Financial Partners first reported a position in RCKT in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.01K in Q1 2026. 57 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

  • Root Financial Partners held 486 shares of Rocket Pharmaceuticals worth $1.28K as of Q3 2026.
  • Rocket Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2850 holding.
  • Root Financial Partners first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Root Financial Partners's Rocket Pharmaceuticals position peaked at $3.01K in Q1 2026.
  • 57 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.